Abstract

Leishmaniasis is an infectious disease caused by the protozoan parasite Leishmania. The three common clinical manifestations of the disease are cutaneous leishmaniasis, which is associated with chronic ulcers of the skin; mucocutaneous leishmaniasis, which is caused by the metastatic spread of Leishmania from a primary cutaneous source to the mucous membranes of the nose, mouth, or pharynx, where it causes destructive lesions; and visceral leishmaniasis or kala-azar, which is associated with fever, chronic weight loss, anorexia, marked splenomegaly, and pancytopenia.

Keywords

Malaria Amphotericin Antimony Glucan Trop 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literature Cited

  1. Chulay, J. D., and A. D. Bryceson. 1983. Quantitation of amastigotes of Leishmania donovani in smears of splenic aspirates from patients with visceral leishmaniasis. Am. J. Trop. Med. Hyg. 32:475–479.PubMedGoogle Scholar
  2. Evans, D. A., S. M. Lanham, C. I. Baldwin, and W. Peters. 1984. The isolation and isoenzyme characterization of Leishmania braziliensis subsp. from patients with cutaneous leishmaniasis acquired in Belize. Trans. R. Soc. Trop. Med. Hyg. 78:35–42.PubMedCrossRefGoogle Scholar
  3. Gustafson, T. L., C. M. Reed, P. B. McGreevy, M. G. Pappas, J. C. Fox, and P. G. Lawyer. 1985. Human cutaneous leishmaniasis acquired in Texas. Am. J. Trop. Med. Hyg. 34:58–63.PubMedGoogle Scholar
  4. Hockmeyer, W. T., P. A. Kager, P. H. Rees, and L. D. Hendricks. 1981. The culture of Leishmania donovani in Schneider’s insect medium: its value in the diagnosis and management of patients with visceral leishmaniasis. Trans. R. Soc. Trop. Med. Hyg. 75:861–863.PubMedCrossRefGoogle Scholar
  5. Kreutzer, R. D., M. E. Semko, L. D. Hendricks, and N. Wright. 1983. Identification of Leishmania spp. by multiple isozyme analysis. Am. J. Trop. Med. Hyg. 32:703–715.PubMedGoogle Scholar
  6. Lynch, N. R., C. Malave, R. B. Ifante, R. L. Modlin, and J. Convit. 1986. In situ detection of amastigotes in American cutaneous leishmaniasis, using monoclonal antibodies. Trans. R. Soc. Trop. Med. Hyg. 80:6–9.PubMedCrossRefGoogle Scholar
  7. Marsden, P. D. 1984. Selective primary health care: strategies for control of disease in the developing world. XIV. Leishmaniasis. Rev. Infect. Dis. 6:736–744.CrossRefGoogle Scholar
  8. Pearson, R. D., D. A. Wheeler, L. H. Harrison, and H. D. Kay. 1983. The immunobiology of leishmaniasis. Rev. Infect. Dis. 5:907–927.PubMedCrossRefGoogle Scholar
  9. Pratt, D. M., and J. R. David. 1981. Monoclonal antibodies that distinguish between New World species of Leishmania. Nature (London) 291:581–583.CrossRefGoogle Scholar
  10. Wirth, D. F., and D. M. Pratt. 1982. Rapid identification of Leishmania species by specific hybridization of kinetoplast DNA in cutaneous lesions. Proc. Natl. Acad. Sei. USA 79:6999–7003.CrossRefGoogle Scholar
  11. World Health Organization. 1984. The leishmaniases: Report of a W.H.O. expert committee. Technical report series no. 701. World Health Organization, Geneva.Google Scholar

Copyright information

© Springer-Verlag New York Inc. 1988

Authors and Affiliations

  • Thomas R. Navin

There are no affiliations available

Personalised recommendations